mRNA therapeutics is a rapidly expanding industry

mRNA therapeutics market expected to reach USD 25 billion by 2030

Personalised Treatments with mRNA

Breakthrough research that shows a promising future for personalised cancer therapy

Secure your place

Development of mRNA Technology

The best technologies and what works most effectively to help with manufacturing and other stages of mRNA development

View the latest program

Expert Speakers to Date

Jeff Gilmore
cGMPnow
Andrew Mancini
Marken
Elisa Cuevas
4basebio
Divita Gilles
DIVINCELL
Jessica Kenison
Mass General Brigham
Amy Rappaport
Gritstone bio
Daniel Griffith Anderson
Massachusetts Institute of Technology
Suresh Peddigari
Moderna
Stuart Milstein
Senda Biosciences
Gilles Besin
Orbital Therapeutics

Past Attendees

GenVault
Macherey-Nagel
Orna Therapeutics
Beckman Coulter Life Sciences
University of Pennsylvania
ProtaGene
CSL Seqirus
University of Washington (Seattle)
Shanghai Jiao Tong University, School of Medicine
Catalent Pharma Solutions
cGMPnow
EMD Serono
Emergent Bioservices
MINISTRY OF HEALTH, MALAYSIA
HealthMatch

Who should attend

mRNA Therapeutics
Immunotherapeutics
Blockchain Technology
mRNA Technologies
Genetic Engineering
DNA, mRNA Technologies
Viral Vector-Based Vaccines
Nucleic Acid-Based Vaccines
Vaccine Delivery Platforms
Biological Engineering of Vaccines
Structural Vaccinology Projects
Advanced Live-Attenuated Vaccines
Inactivated Vaccine Development
Cost Reduction Strategies
Sales and Marketing Initiatives
Business Development
Clinical Trials and Approvals
Immunisation Research & Development
Manufacturing Research & Innovation
Research and Development
Strategy, Projects, & Public Affairs
Legal and Compliance Work
Equipment Certification Services
News Reporting and Journalism
Biotechnology Companies
Pharmaceutical Companies
Vaccination Developers
Vaccine Researchers
Vaccine Technology Companies
Immunisation Specialists
Public Healthcare Providers
Genetic Engineering Companies
Global Healthcare Institutions
Clinical Research Organisations
Vaccine Delivery Technologies
Vaccines Manufacturing
Vaccinology Research & Development
Biological Engineering Companies
DNA and Messenger RNA Researchers
International Quality Standards
Associations and Alliances
Universities and Academia
Research and Development
Government Agencies
Consultants and Advisors
Public Consultation Groups
Legal and Compliance Services
News Reporters and Journalists

Why Attend

The mRNA Conference is the only event to deliver leading market intelligence and industry presentations on the latest in next-generation mRNA therapeutics, formulations, and clinical development.…

Subscribe for updates:

The Premier Forum for mRNA-Based Therapeutics and Drug Development

Welcome to The mRNA Conference 2024, where global pharmaceutical and biotech companies will meet with world-leading industry experts in Frankfurt, Germany, to explore the latest innovations in mRNA-based therapeutics and vaccines for infectious diseases, oncology, CAR-T cell therapies, and beyond.

Recent vaccine success has put mRNA technology into the spotlight with increasingly growing potential for applications in immunotherapy, personalised medicine, and clinical treatments of genetic, infectious, and chronic diseases. The mRNA conference will focus on developing mRNA vaccines and therapies from early research to commercialisation and clinical applications.

This exclusive event will showcase invaluable insights into differentiated drug platforms through RNA modification and delivery systems, next-generation mRNA therapeutics, formulations, clinical development, and supply chain and logistics.

Key topics on this year’s agenda include:

The future of mRNA-based therapeutics for infectious disease and beyond
Latest advancements in mRNA formulation and delivery technologies
Breakthrough research in personalised mRNA treatments and immunotherapy
Blockchain technology for mRNA-based therapeutics supply chain solutions
Challenges and bottlenecks in the global manufacturing of mRNA vaccines
Regulatory and healthcare considerations in mRNA-based clinical development

The mRNA Conference 2024 is set to become the world’s leading event exclusively for the biotech and pharma industry to meet and collaborate with RNA technology experts, examine new technologies and technical know-how, and discuss the opportunities associated with next-generation mRNA therapeutics, formulations, and clinical development.

Call for Presentation

If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading “Call for Papers - The mRNA Conference 2024”.

Book now
To secure your place at The mRNA Conference 2024 or if you require more information, please contact delegates@iQ-Hub.com.

SPONSORS / EXHIBITORS

Key topics for 2024:

The future of mRNA-based therapeutics for infectious disease and beyond
Hear about innovations, the limitless future of mRNA therapeutics, and a new class of drugs.
Latest advancements in mRNA formulation and delivery technologies
Learn about delivering the messenger and technological advancements for therapeutic mRNA delivery from concept to clinical reality.
Breakthrough research in personalised mRNA treatments and immunotherapy
Understand the most recent technological advances towards personalised, tumor-specific, mRNA therapeutic vaccines for cancer.
Blockchain technology for mRNA-based therapeutics supply chain solutions
Gain insight into the blockchain-enabled pharmaceutical cold chain and supply chain transparency through blockchain-based traceability.
Challenges and bottlenecks in the global manufacturing of mRNA vaccines
Explore the latest innovative and rapid development and deployment of high‐volume vaccines for pandemic responses.
Regulatory and healthcare considerations in mRNA-based clinical development
Learn the key regulatory and commercial concerns to approve and accept mRNA-based therapeutics to treat diseases.

Testimonials

Highly informational event with lots of opportunities to engage with other people from the field.
Ying Wang, Johnson & Johnson
Excellent speaker line up. Showcasing the science and results from across the industry.
Anne Renton, Merck
Well organized and great discussions. Networking opportunities were excellent.
Carolyn Dulney, Roche
Provided a great learning opportunity and served as a very good networking event.
Mike Zimmer, Novartis
I loved the show! Very informative conference and a great group of people.
Wensheng Du, GlaxoSmithKline
Excellent conference. Very useful information. Well organized event and agenda was very appropriate.
Barry Rosen, Sanofi